← Back to Search

Meditation for Brain Health (BLISS Trial)

N/A

Recruiting

Led By Balachundar Subramaniam, MD, MPH

Research Sponsored by Beth Israel Deaconess Medical Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up measured at baseline and 6 months

Awards & highlights

BLISS Trial Summary

This trial will study the effects of a 21-minute meditation on brain health and function.

Who is the study for?

This trial is for Massachusetts residents aged 20-65 who can understand the study and consent to participate. It's not for pregnant individuals, non-English speakers, those with less than a high school education, or anyone in another study that could affect results. People with recent substance abuse, significant visual impairment, history of certain neurological issues or psychiatric illnesses are also excluded.Check my eligibility

What is being tested?

The trial tests if Shambhavi Mahamudra Kriya—a 21-minute meditation practice—can improve brain health and cognitive function. Participants will regularly perform this meditation to see its effects on their mental and physiological state.See study design

What are the potential side effects?

Meditation practices like Shambhavi Mahamudra Kriya typically have minimal side effects; however, some individuals may experience discomfort during sitting, mild headaches or fatigue post-meditation. Rarely it might trigger emotional distress if underlying psychological conditions are present.

BLISS Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ measured at baseline and 6 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~measured at baseline and 6 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and measured at baseline and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in Frontal Midline Theta Power after 6 Months of Daily Meditation Practice

Change in Gamma Slope Index (GSI) after 6 Months of Daily Meditation

Secondary outcome measures

Change in Brain Connectivity after 6 Months of Daily Meditation Practice

Change in Brain cortical thickness after 6 Months of Daily Meditation Practice

Brain

BLISS Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Wellness and Meditation-Based InterventionExperimental Treatment1 Intervention

Shambhavi Mahamudra Kriya: a multi-component 21-minute meditation that incorporates a combination of different breathing patterns and meditative components.

Group II: ControlActive Control1 Intervention

Control Group: selected to be age, gender and education level matched with the intervention group and will be asked to continue their daily routine while completing surveys at each timepoint.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Beth Israel Deaconess Medical CenterLead Sponsor

837 Previous Clinical Trials

13,010,192 Total Patients Enrolled

2 Trials studying Meditation

42 Patients Enrolled for Meditation

Balachundar Subramaniam, MD, MPHPrincipal InvestigatorBeth Israel Deaconess Medical Center

3 Previous Clinical Trials

389 Total Patients Enrolled

Media Library

Shambhavi Madamudra Kriya Clinical Trial Eligibility Overview. Trial Name: NCT05455814 — N/A

Meditation Research Study Groups: Wellness and Meditation-Based Intervention, Control

Meditation Clinical Trial 2023: Shambhavi Madamudra Kriya Highlights & Side Effects. Trial Name: NCT05455814 — N/A

Shambhavi Madamudra Kriya 2023 Treatment Timeline for Medical Study. Trial Name: NCT05455814 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there a predetermined demographic of individuals that can partake in this clinical study?

"This trial is targeting 80 participants between the ages of 20 and 65 who have already been diagnosed with a medical condition. To be eligible, individuals must meet this criteria."

Answered by AI

Are there still open slots for participants in this medical experiment?

"The records on clinicaltrials.gov demonstrate that the recruitment period for this trial has ended, with its initial posting occurring on September 1st 2022 and a final edit taking place August 22nd 2022. Nonetheless, there are currently 7 other trials in search of participants at this time."

Answered by AI